drugset / Trial / NCT01103206
Evaluation of a Cincalcet Suppression Test
Phase 4
Completed
36 enrolled
University Hospital, Rouen
Institut National de la Santé Et de la Recherche Médicale, France · collab
RandomizedCrossoverOpen-labelDiagnostic
Summary
The aim of the study is to compare the results of a parathyroid hormone (PTH)suppression test using a single oral tablet of cinacalcet in two groups of subjects: 1- a group of healthy adults in whom the results of the test with cinacalcet will be compared with those of the standardized PTH suppression test with intravenous calcium loading; 2- a group of patients with proven primary hyperparathyroidism in whom the results of the test with cinacalcet will be compared with those obtained during the same test, in healthy controls.
Timeline
- Start
- 2010-04
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cinacalcet | Other / unclassified | 30 mg | Oral |
| Subject | Cinacalcet | Other / unclassified | 60 mg | Oral |
Indications
No indication recorded.